News

The adjusted odds for having oropharyngeal gonorrhea were 1.46-fold for men with ≥4 kissing-only partners and 1.81-fold for men with ≥4 kissing-with-sex partners.

At MAD-ID 2019, Alison Lew, PharmD, spoke about her research on oral vancomycin prophylaxis to reduce CDI recurrence.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 12, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

According to the CDC, 28% of the Salmonella cases in this outbreak occurred in children under the age of 5 years.

With a shortage in specialists, the service could help address an issue that costs health care billions of dollars a year.

A revision to the fluoroquinolone antimicrobial susceptibility testing breakpoints for 2 bacteria comes following evidence that previous breakpoints were too high to detect low-level antibiotic resistance.

A new study finds involving bedside nurses in antimicrobial stewardship and infection prevention can yield major results in a short amount of time.

A multifaceted intervention has tripled the rate of hepatitis C virus screening in a baby boomer population.

A new study gives hope in the fight against multidrug-resistant bacteria.

Renee Ackley, PharmD, BCPS, discusses her research ceftazidime/avibactam and meropenem/vaborbactam for treatment of CRE infections.

Does pharmacist presence in an urgent care center have an effect on antibiotic prescribing practices?

Consumption of oysters from a Mexican estuary has led to infections caused by multiple pathogens, with some individuals infected by more than 1 bug.

Agreement between Gilead and Trump administration promises more drugs for at-risk patients.

Following a rise in sexually transmitted infection diagnoses in recent years, NIAID is awarding grants for research into syphilis, gonorrhea, and chlamydia vaccine candidates.

Contagion® editor-in-chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, recaps his presentations from MAD-ID 2019.

Treating men with UTIs for longer than 7 days shows no clinical benefits and is associated with increased risk of recurrence.

As clinician are growing interested in the use of extended infusion beta-lactams for gram-negative bacteremia, a team of investigators noticed that available data are unclear and solely focus on clinical cure and/or mortality outcomes.

At MAD-ID 2019, Monica V. Mahoney, PharmD, BCPS (AQID), BCIDP, presented a workshop on formulary management strategies in antimicrobial stewardship.

One company's bankruptcy sheds light on a deeply worrisome reality.

A study found that patients with complicated C diff infections were more likely to have been previously hospitalized with numerically less time between hospitalization and recent C diff episode.

Brandon J. Smith, MD, PharmD, describes a case of a patient who was treated for mycobacterial infection after ground-glass opacity was detected in her lung.

Ryan K. Shields, PharmD, MS, discusses his research presented at MAD-ID 2019 on T2Candida's place in rational antifungal management.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 5, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The total number of bed days saved with outpatient oritavancin administration was 683 days throughout the study period.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.